By Sharon Lamb, Gary Howes and Bella North on Apr 28, 2021
Posted In Employee Benefits, Health and Welfare Plans
The combination of the Coronavirus (COVID-19) pandemic and the imminent end of the Brexit transition period means a fast-changing regulatory environment for medicines. In October 2020, the UK Government made changes to the regulation of medicines for COVID-19 and influenza. The regulations set out changes for the temporary authorisation of medicines (including COVID-19 vaccines) and...